Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 5525

1.

Associations of Assisted Reproductive Technology and Twin Pregnancy With Risk of Congenital Heart Defects.

Wen SW, Miao Q, Taljaard M, Lougheed J, Gaudet L, Davies M, Lanes A, Leader A, Corsi DJ, Sprague AE, Walker M.

JAMA Pediatr. 2020 Feb 24. doi: 10.1001/jamapediatrics.2019.6096. [Epub ahead of print]

PMID:
32091547
2.

Risks to people from raw pet food.

Davies M.

Vet Rec. 2020 Feb 22;186(7):220-221. doi: 10.1136/vr.m629. No abstract available.

PMID:
32086417
3.

Outcomes of isolated inframalleolar interventions for chronic limb-threatening ischemia in diabetic patients.

Cheun TJ, Jayakumar L, Sideman MJ, Pounds LC, Davies MG.

J Vasc Surg. 2020 Feb 17. pii: S0741-5214(19)32189-5. doi: 10.1016/j.jvs.2019.07.094. [Epub ahead of print]

PMID:
32081478
4.

UV oxidation of cyclic AMP receptor protein, a global bacterial gene regulator, decreases DNA binding and cleaves DNA at specific sites.

Leinisch F, Mariotti M, Andersen SH, Lindemose S, Hägglund P, Møllegaard NE, Davies MJ.

Sci Rep. 2020 Feb 20;10(1):3106. doi: 10.1038/s41598-020-59855-x.

5.

Toxicity management with combination chemotherapy and programmed death 1/programmed death ligand 1 inhibitor therapy in advanced lung cancer.

Hoffner B, Leighl NB, Davies M.

Cancer Treat Rev. 2020 Feb 4;85:101979. doi: 10.1016/j.ctrv.2020.101979. [Epub ahead of print] Review.

PMID:
32078962
6.

Efficacy and tolerability of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: A systematic review and network meta-analysis.

Hussein H, Zaccardi F, Khunti K, Davies MJ, Patsko E, Dhalwani NN, Kloecker DE, Ioannidou E, Gray LJ.

Diabetes Obes Metab. 2020 Feb 19. doi: 10.1111/dom.14008. [Epub ahead of print] Review.

PMID:
32077218
7.

Anterior translation of the tibia in relation to femur in mucoid degeneration of ACL - An observational study.

Saad A, Waldron D, Iqbal A, Evans S, Panchal H, James S, Davies M, Botchu R.

J Orthop. 2020 Feb 4;18:240-243. doi: 10.1016/j.jor.2020.02.005. eCollection 2020 Mar-Apr.

PMID:
32071511
8.

A Cost and Cost-Benefit Analysis of the Stand More AT Work (SMArT Work) Intervention.

Munir F, Miller P, Biddle SJH, Davies MJ, Dunstan DW, Esliger DW, Gray LJ, O'Connell SE, Waheed G, Yates T, Edwardson CL.

Int J Environ Res Public Health. 2020 Feb 13;17(4). pii: E1214. doi: 10.3390/ijerph17041214.

9.

Cost-effectiveness of intensive interventions compared to standard care in individuals with type 2 diabetes: A systematic review and critical appraisal of decision-analytic models.

Usman M, Khunti K, Davies MJ, Gillies CL.

Diabetes Res Clin Pract. 2020 Feb 12;161:108073. doi: 10.1016/j.diabres.2020.108073. [Epub ahead of print]

PMID:
32061637
10.

Effectiveness and cost of integrating a pragmatic pathway for prescribing liraglutide 3.0 mg in obesity services (STRIVE study): study protocol of an open-label, real-world, randomised, controlled trial.

Papamargaritis D, Al-Najim W, Lim J, Crane J, Lean M, le Roux C, McGowan B, O'Shea D, Webb D, Wilding J, Davies MJ.

BMJ Open. 2020 Feb 13;10(2):e034137. doi: 10.1136/bmjopen-2019-034137.

11.

Risk Factors for Heart Failure: 20-Year Population-Based Trends by Sex, Socioeconomic Status, and Ethnicity.

Lawson CA, Zaccardi F, Squire I, Okhai H, Davies M, Huang W, Mamas M, Lam CSP, Khunti K, Kadam UT.

Circ Heart Fail. 2020 Feb;13(2):e006472. doi: 10.1161/CIRCHEARTFAILURE.119.006472. Epub 2020 Feb 14.

PMID:
32059630
12.

Priorities of patients with multimorbidity and of clinicians regarding treatment and health outcomes: a systematic mixed studies review.

Sathanapally H, Sidhu M, Fahami R, Gillies C, Kadam U, Davies MJ, Khunti K, Seidu S.

BMJ Open. 2020 Feb 12;10(2):e033445. doi: 10.1136/bmjopen-2019-033445.

13.

Management of Pneumonitis and Neuropathy in Patients Receiving PD-1-Based Therapy for Non-Small-Cell Lung Cancer.

Davies MJ, Chiang AC.

JCO Oncol Pract. 2020 Feb;16(2_suppl):4s-9s. doi: 10.1200/JOP.19.00676.

PMID:
32045539
14.

The Relationship between Residual Kidney Function and Symptom Burden in Hemodialysis Patients.

Kong JH, Davies MR, Mount PF.

Intern Med J. 2020 Feb 11. doi: 10.1111/imj.14775. [Epub ahead of print]

PMID:
32043691
15.

Implications of early failure of isolated endovascular tibial interventions.

Cheun TJ, Jayakumar L, Ferrer L, Miserlis D, Mitromaras C, Sideman MJ, Davies MG.

J Vasc Surg. 2020 Feb 5. pii: S0741-5214(19)32859-9. doi: 10.1016/j.jvs.2019.11.035. [Epub ahead of print]

PMID:
32035771
16.

Structure-Based Design and Pharmacokinetic Optimization of Covalent Allosteric Inhibitors of the Mutant GTPase KRASG12C.

Kettle JG, Bagal SK, Bickerton S, Bodnarchuk MS, Breed J, Carbajo RJ, Cassar DJ, Chakraborty A, Cosulich S, Cumming I, Davies M, Eatherton A, Evans L, Feron L, Fillery S, Gleave ES, Goldberg FW, Harlfinger S, Hanson L, Howard M, Howells R, Jackson A, Kemmitt P, Kingston JK, Lamont S, Lewis HJ, Li S, Liu L, Ogg D, Phillips C, Polanski R, Robb G, Robinson D, Ross S, Smith JM, Tonge M, Whiteley R, Yang J, Zhang L, Zhao X.

J Med Chem. 2020 Feb 13. doi: 10.1021/acs.jmedchem.9b01720. [Epub ahead of print]

PMID:
32023060
17.

Pragmatic management of low-energy diets in people with type 2 diabetes in primary care: a decision aid for clinicians.

Baldry EL, Davies MJ, Khunti K, Webb DR.

Diabet Med. 2020 Feb 5. doi: 10.1111/dme.14265. [Epub ahead of print] No abstract available.

PMID:
32020691
18.

Long non-coding RNA dysregulation is a frequent event in non-small cell lung carcinoma pathogenesis.

Acha-Sagredo A, Uko B, Pantazi P, Bediaga NG, Moschandrea C, Rainbow L, Marcus MW, Davies MPA, Field JK, Liloglou T.

Br J Cancer. 2020 Feb 5. doi: 10.1038/s41416-020-0742-9. [Epub ahead of print]

PMID:
32020063
19.

Circulating tumor cells and early relapse in node-positive melanoma.

Lucci A, Hall C, Patel SP, Narendran B, Bauldry JB, Royal R, Karhade M, Upshaw JR, Wargo JA, Glitza IC, Wong MKK, Amaria RN, Tawbi HA, Diab A, Davies MA, Gershenwald JE, Lee JE, Hwu P, Ross MI.

Clin Cancer Res. 2020 Feb 3. pii: clincanres.2670.2019. doi: 10.1158/1078-0432.CCR-19-2670. [Epub ahead of print]

PMID:
32015020
20.

Tailored regimens for combined hormonal contraceptives.

Nash Z, Thwaites A, Davies M.

BMJ. 2020 Feb 3;368:m200. doi: 10.1136/bmj.m200. No abstract available.

PMID:
32014854
21.

Epidural Blood Patch as a diagnostic and therapeutic intervention in Spontaneous Intracranial Hypotension - a novel approach to management.

Davies MJ, Davies MA, Sharpe R, Cordato D, Schwartz R.

World Neurosurg. 2020 Jan 28. pii: S1878-8750(20)30181-9. doi: 10.1016/j.wneu.2020.01.163. [Epub ahead of print]

PMID:
32004736
22.

Characterizing the double-sided cascade of care for adolescents living with HIV transitioning to adulthood across Southern Africa.

Tsondai PR, Sohn AH, Phiri S, Sikombe K, Sawry S, Chimbetete C, Fatti G, Hobbins MA, Technau KG, Rabie H, Bernheimer J, Fox MP, Judd A, Collins IJ, Davies MA; International epidemiology to Evaluate AIDS Southern Africa (IeDEA-SA) Collaboration.

J Int AIDS Soc. 2020 Jan;23(1):e25447. doi: 10.1002/jia2.25447.

23.

Theatre: A Taste of Honey: I'm not Happy and I'm not Sad.

Davies M.

Br J Gen Pract. 2020 Jan 30;70(691):78. doi: 10.3399/bjgp20X707933. Print 2020 Feb. No abstract available.

PMID:
32001467
24.

Priority access to health care: Evidence from an exogenous policy shock.

Yee CA, Legler A, Davies M, Prentice J, Pizer S.

Health Econ. 2020 Mar;29(3):306-323. doi: 10.1002/hec.3982. Epub 2020 Jan 30.

PMID:
31999884
25.

A longitudinal analysis of the completeness of maternal HIV testing, including repeat testing in Cape Town, South Africa.

de Beer S, Kalk E, Kroon M, Boulle A, Osler M, Euvrard J, Timmerman V, Davies MA.

J Int AIDS Soc. 2020 Jan;23(1):e25441. doi: 10.1002/jia2.25441.

26.

Burden of Cardiovascular Disease in Adult Patients with Type 1 Diabetes in the US.

Edelman S, Zhou FL, Preblick R, Verma S, Paranjape S, Davies MJ, Joish VN.

Pharmacoecon Open. 2020 Jan 29. doi: 10.1007/s41669-019-00192-9. [Epub ahead of print]

27.

Cumulative Incidence and Predictors of CNS Metastasis for Patients With American Joint Committee on Cancer 8th Edition Stage III Melanoma.

Haydu LE, Lo SN, McQuade JL, Amaria RN, Wargo J, Ross MI, Cormier JN, Lucci A, Lee JE, Ferguson SD, Saw RPM, Spillane AJ, Shannon KF, Stretch JR, Hwu P, Patel SP, Diab A, Wong MKK, Glitza Oliva IC, Tawbi H, Carlino MS, Menzies AM, Long GV, Lazar AJ, Tetzlaff MT, Scolyer RA, Gershenwald JE, Thompson JF, Davies MA.

J Clin Oncol. 2020 Jan 28:JCO1901508. doi: 10.1200/JCO.19.01508. [Epub ahead of print]

PMID:
31990608
28.

The role of myeloperoxidase (MPO) in biomolecule modification, chronic inflammation and disease.

Davies MD, Hawkins CL.

Antioxid Redox Signal. 2020 Jan 28. doi: 10.1089/ars.2020.8030. [Epub ahead of print]

PMID:
31989833
29.

The (Slow) Depathologizing of Gender Incongruence.

Davies RD, Davies ME.

J Nerv Ment Dis. 2020 Feb;208(2):152-154. doi: 10.1097/NMD.0000000000001119.

PMID:
31977826
30.

Quantifying the Impact of Patient-Practice Relationship Quality on the Levels of the Average Annual Antidepressant Practice Prescribing Rate in Primary Care in England.

Heald AH, Stedman M, Davies M, Farman S, Taylor D, Bailey S, Gadsby R.

Prim Care Companion CNS Disord. 2020 Jan 16;22(1). pii: 19m02528. doi: 10.4088/PCC.19m02528.

31.

Binding of myeloperoxidase to the extracellular matrix of smooth muscle cells and subsequent matrix modification.

Cai H, Chuang CY, Hawkins CL, Davies MJ.

Sci Rep. 2020 Jan 20;10(1):666. doi: 10.1038/s41598-019-57299-6.

32.

Therapeutic efficacy and safety of initial triple combination of metformin, sitagliptin, and lobeglitazone in drug-naïve patients with type 2 diabetes: initial triple study.

Lim S, Ku EJ, Lee SY, Lee JH, Lee JE, Kim KM, Davies MJ.

BMJ Open Diabetes Res Care. 2020 Jan;8(1). pii: e000807. doi: 10.1136/bmjdrc-2019-000807.

33.

Coordinated Targeting of Galanin Receptors on Cholangiocytes and Hepatic Stellate Cells Ameliorates Liver Fibrosis in Multidrug Resistance Protein 2 Knockout Mice.

Petrescu AD, Grant S, Williams E, Frampton G, Parks N, Blaney H, Davies M, John R, Reinhart EH, McMillin M, DeMorrow S.

Am J Pathol. 2020 Jan 14. pii: S0002-9440(20)30003-1. doi: 10.1016/j.ajpath.2019.10.023. [Epub ahead of print]

PMID:
31953035
34.

B cells and tertiary lymphoid structures promote immunotherapy response.

Helmink BA, Reddy SM, Gao J, Zhang S, Basar R, Thakur R, Yizhak K, Sade-Feldman M, Blando J, Han G, Gopalakrishnan V, Xi Y, Zhao H, Amaria RN, Tawbi HA, Cogdill AP, Liu W, LeBleu VS, Kugeratski FG, Patel S, Davies MA, Hwu P, Lee JE, Gershenwald JE, Lucci A, Arora R, Woodman S, Keung EZ, Gaudreau PO, Reuben A, Spencer CN, Burton EM, Haydu LE, Lazar AJ, Zapassodi R, Hudgens CW, Ledesma DA, Ong S, Bailey M, Warren S, Rao D, Krijgsman O, Rozeman EA, Peeper D, Blank CU, Schumacher TN, Butterfield LH, Zelazowska MA, McBride KM, Kalluri R, Allison J, Petitprez F, Fridman WH, Sautès-Fridman C, Hacohen N, Rezvani K, Sharma P, Tetzlaff MT, Wang L, Wargo JA.

Nature. 2020 Jan;577(7791):549-555. doi: 10.1038/s41586-019-1922-8. Epub 2020 Jan 15.

PMID:
31942075
35.

FOXD3 Regulates VISTA Expression in Melanoma.

Rosenbaum SR, Knecht M, Mollaee M, Zhong Z, Erkes DA, McCue PA, Chervoneva I, Berger AC, Lo JA, Fisher DE, Gershenwald JE, Davies MA, Purwin TJ, Aplin AE.

Cell Rep. 2020 Jan 14;30(2):510-524.e6. doi: 10.1016/j.celrep.2019.12.036.

36.

Targeting BRD/BET proteins inhibits adaptive kinome upregulation and enhances the effects of BRAF/MEK inhibitors in melanoma.

Tiago M, Capparelli C, Erkes DA, Purwin TJ, Heilman SA, Berger AC, Davies MA, Aplin AE.

Br J Cancer. 2020 Jan 14. doi: 10.1038/s41416-019-0724-y. [Epub ahead of print]

PMID:
31932756
37.

A randomised controlled trial to determine patient experience of a magnetostrictive stack scaler as compared to a piezoelectric scaler, in supportive periodontal therapy.

Daly S, Newcombe RG, Claydon NCA, Seong J, Davies M, West NX.

J Dent. 2020 Feb;93:103279. doi: 10.1016/j.jdent.2020.103279. Epub 2020 Jan 10.

PMID:
31931025
38.

From Paris to Montreal: disease regression is common during long term follow-up of paediatric Crohn's disease.

Davies M, Dodd S, Coultate M, Ross A, Pears G, Gnaneswaran B, Tzivinikos C, Konidari A, Cheng J, Auth MK, Cameron F, Tamhne S, Renji E, Nair M, Baillie C, Collins P, Smith PJ, Subramanian S.

Scand J Gastroenterol. 2020 Jan 12:1-6. doi: 10.1080/00365521.2019.1710765. [Epub ahead of print]

PMID:
31928099
39.

Modification of Cys residues in human thioredoxin-1 by p-benzoquinone causes inhibition of its catalytic activity and activation of the ASK1/p38-MAPK signalling pathway.

Shu N, Hägglund P, Cai H, Hawkins CL, Davies MJ.

Redox Biol. 2020 Jan;29:101400. doi: 10.1016/j.redox.2019.101400. Epub 2019 Dec 6.

40.

Leptomeningeal disease in melanoma patients: An update to treatment, challenges, and future directions.

Glitza IC, Smalley KSM, Brastianos PK, Davies MA, McCutcheon I, Liu JKC, Ahmed KA, Arrington JA, Evernden BR, Smalley I, Eroglu Z, Khushalani N, Margolin K, Kluger H, Atkins MB, Tawbi H, Boire A, Forsyth P.

Pigment Cell Melanoma Res. 2020 Jan 8. doi: 10.1111/pcmr.12861. [Epub ahead of print] Review.

PMID:
31916400
41.

Analysis of Global Collection of Group A Streptococcus Genomes Reveals that the Majority Encode a Trio of M and M-Like Proteins.

Frost HR, Davies MR, Delforge V, Lakhloufi D, Sanderson-Smith M, Srinivasan V, Steer AC, Walker MJ, Beall B, Botteaux A, Smeesters PR.

mSphere. 2020 Jan 8;5(1). pii: e00806-19. doi: 10.1128/mSphere.00806-19.

42.

Immune-mediated genetic pathways resulting in pulmonary function impairment increase lung cancer susceptibility.

Kachuri L, Johansson M, Rashkin SR, Graff RE, Bossé Y, Manem V, Caporaso NE, Landi MT, Christiani DC, Vineis P, Liu G, Scelo G, Zaridze D, Shete SS, Albanes D, Aldrich MC, Tardón A, Rennert G, Chen C, Goodman GE, Doherty JA, Bickeböller H, Field JK, Davies MP, Dawn Teare M, Kiemeney LA, Bojesen SE, Haugen A, Zienolddiny S, Lam S, Le Marchand L, Cheng I, Schabath MB, Duell EJ, Andrew AS, Manjer J, Lazarus P, Arnold S, McKay JD, Emami NC, Warkentin MT, Brhane Y, Obeidat M, Martin RM, Relton C, Davey Smith G, Haycock PC, Amos CI, Brennan P, Witte JS, Hung RJ.

Nat Commun. 2020 Jan 7;11(1):27. doi: 10.1038/s41467-019-13855-2.

43.

Comparison of Complication and Reoperation Rates for Minimally Invasive Versus Open Cheilectomy of the First Metatarsophalangeal Joint.

Stevens R, Bursnall M, Chadwick C, Davies H, Flowers M, Blundell C, Davies M.

Foot Ankle Int. 2020 Jan;41(1):31-36. doi: 10.1177/1071100719873846. Epub 2019 Sep 6.

PMID:
31910054
44.

Short-term contemporary outcomes for staged versus primary lower limb amputation in diabetic foot disease.

Cheun TJ, Jayakumar L, Sideman MJ, Ferrer L, Mitromaras C, Miserlis D, Davies MG.

J Vasc Surg. 2019 Dec 31. pii: S0741-5214(19)32634-5. doi: 10.1016/j.jvs.2019.10.083. [Epub ahead of print]

PMID:
31901363
45.

Safety and Effectiveness of Isoniazid Preventive Therapy in HIV-Positive Pregnant Women on Art: An Observational Study using Linked Population Data.

Kalk E, Heekes A, Mehta U, de Waal R, Jacob N, Cohen K, Myer L, Davies MA, Maartens G, Boulle A.

Clin Infect Dis. 2020 Jan 4. pii: ciz1224. doi: 10.1093/cid/ciz1224. [Epub ahead of print]

PMID:
31900473
46.

Predictors of the Acute Postprandial Response to Breaking Up Prolonged Sitting.

Henson J, Edwardson CL, Celis-Morales CA, Davies MJ, Dunstan DW, Esliger DW, Gill JMR, Kazi A, Khunti K, King J, McCarthy M, Sattar N, Stensel DJ, Velayudhan L, Zaccardi F, Yates T.

Med Sci Sports Exerc. 2020 Feb 5. doi: 10.1249/MSS.0000000000002249. [Epub ahead of print]

PMID:
31895295
47.

Correction to: Use of Urban Health Indicator Tools by Built Environment Policy- and Decision-Makers: a Systematic Review and Narrative Synthesis.

Pineo H, Glonti K, Rutter H, Zimmermann N, Wilkinson P, Davies M.

J Urban Health. 2019 Dec 26. doi: 10.1007/s11524-019-00392-y. [Epub ahead of print]

PMID:
31879848
48.

Identification of binding residues between periplasmic adapter protein (PAP) and RND efflux pumps explains PAP-pump promiscuity and roles in antimicrobial resistance.

McNeil HE, Alav I, Torres RC, Rossiter AE, Laycock E, Legood S, Kaur I, Davies M, Wand M, Webber MA, Bavro VN, Blair JMA.

PLoS Pathog. 2019 Dec 26;15(12):e1008101. doi: 10.1371/journal.ppat.1008101. eCollection 2019 Dec.

49.

Real-world outcomes of treatment with insulin glargine 300 U/mL versus standard-of-care in people with uncontrolled type 2 diabetes mellitus.

Freemantle N, Mauricio D, Giaccari A, Bailey T, Roussel R, Franco D, Berthou B, Pilorget V, Westerbacka J, Bosnyak Z, Bonnemaire M, Cali AMG, Nguyên-Pascal ML, Penfornis A, Perez-Maraver M, Seufert J, Sullivan SD, Wilding J, Wysham C, Davies M.

Curr Med Res Opin. 2020 Jan 19:1-11. doi: 10.1080/03007995.2019.1708287. [Epub ahead of print]

PMID:
31865758
50.

2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Buse JB, Wexler DJ, Tsapas A, Rossing P, Mingrone G, Mathieu C, D'Alessio DA, Davies MJ.

Diabetes Care. 2020 Feb;43(2):487-493. doi: 10.2337/dci19-0066. Epub 2019 Dec 19.

PMID:
31857443

Supplemental Content

Loading ...
Support Center